Yang Y.,The Chinese Medicine Hospital of Hangzhou |
Yan Z.,The Peoples Hospital Of Zhejiang |
Fu X.,The Chinese Medicine Hospital of Hangzhou |
Dong L.,The Chinese Medicine Hospital of Hangzhou |
And 3 more authors.
Cell Biochemistry and Biophysics | Year: 2014
To analyze the efficacy of different surgical methods in treating palmar hyperhidrosis and the compensatory hyperhidrosis after surgery and to observe the efficacy of “Energy-boosting and Yin-nourishing anti-perspirant formula” on postsurgical hyperhidrosis patients. Two-hundred patients were randomly assigned to groups A (Chinese and Western medicine, T4 transection plus “Energy-boosting and Yin-nourishing anti-perspirant formula”) and B (Western medicine, T4 transection). The surgical efficiency, recurrence rate, compensatory hyperhidrosis, and the long-term life quality were compared. Another 100 cases (group C, T2 transection) were analyzed as a control group. After surgery, the palmar hyperhidrosis and armpit sweating were relieved in all the three group patients and in 34 % of patients combined with plantar hyperhidrosis, the symptoms were relieved. Transient palmar hyperhidrosis was found in three cases at day 2 to day 5 postoperatively. One case of Horner’s syndrome and one case recurrence were found in group C patients. The compensatory sweating of various degrees occurred in all the three groups. There were 25, 24, and 43 cases in groups A, B, and C, respectively. There is a significant difference between groups C, A, and B. The compensatory sweating in 13 cases of group A and four cases of group B had different degrees of improvement in the follow-up 6 months after surgery. There is a significant difference. Thoracoscopic bilateral T4 sympathetic chain and the Kuntz resection are the optimized surgical treatments for the palmar hyperhidrosis. “Energy-boosting and Yin-nourishing anti-perspirant formula” is effective in treating the postoperative compensatory sweating. © 2014, Springer Science+Business Media New York.
Dong Y.-Q.,Zhejiang University |
Dong Y.-Q.,The Chinese Medicine Hospital of Hangzhou |
Lu C.-W.,Zhejiang University |
Zhang L.,Zhejiang University |
And 3 more authors.
Molecular Immunology | Year: 2015
Toll-like receptor (TLR) 4-mediated signaling has been shown to be important to cell survival, invasion and metastasis in a variety of cancers. The present study aimed to explore the role and downstream pathways of TLR4 signaling in the invasion of hepatocellular carcinoma (HCC) cell lines. We found that LPS, the agonist of TLR4, notably enhanced the invasiveness of HCC cells and the expression of MMP2 and MMP9, as well as the production of IL-6 and TNFα. LPS treatment dramatically increased the TLR4 expression on HCC cells surface and MKK4/JNK activation, while knockdown of TLR4 inhibited the LPS-induced invasion and the phosphorylation of MKK4 and JNK. Furthermore, silencing of MKK4 or inhibition of JNK activity led to impaired invasiveness of HCCs, low expression level of MMPs and TLR4, as well as limited production of cytokines. However, LPS stimulation only triggered moderate activation of NF-κB. Silencing of NF-κB or NF-κB inhibitor had no obvious effect on the invasive ability of HCCs and TLR4 expression, but suppressed IL-6 and TNFα production. These findings suggested that LPS-TLR4 signaling enhanced the invasiveness of HCCs mainly through MKK4/JNK pathway. © 2015 Elsevier Ltd.